Explore › Condition › Postpartum depression
Condition

Postpartum depression

Also known as: Depression - postnatal Depression, Post-Natal Depression, Post-Partum Depression, Postnatal Depression, Postpartum Post Natal Depression Post Partum Depression Post-Natal Depression Post-Partum Depression Postnatal Depression Postnatal depression Postnatal depressive disorder +9 more
12 findings 1 paper 6 related entities View in graph →

Related entities

interventions
PREPP (Practical Resources for Effective Postpartum Parenting)4
outcomes
Depressive Symptoms2 infant fuss/cry episodes frequency1 Treatment Adherence1
populations
Postmenopausal Women4
studys
PMC47381664

Findings (50)

None
improvement

Mothers who received PREPP reported significantly fewer bouts of infant fussing and crying at 6 weeks postpartum than mothers in the ETAU group.

Effect: improvement; F (1, 28) = 5.68

Size: F (1, 28) = 5.68
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Mothers who received PREPP reported significantly fewer bouts of infant fussing and crying at 6 weeks postpartum than mothers in the ETAU group.

Effect: improvement; F (1, 28) = 5.68

Size: F (1, 28) = 5.68
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Mothers who received PREPP reported significantly fewer bouts of infant fussing and crying at 6 weeks postpartum than mothers in the ETAU group.

Effect: improvement; F (1, 28) = 5.68

Size: F (1, 28) = 5.68
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Mothers who received PREPP reported significantly fewer bouts of infant fussing and crying at 6 weeks postpartum than mothers in the ETAU group.

Effect: improvement; F (1, 28) = 5.68

Size: F (1, 28) = 5.68
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Mothers who received PREPP reported significantly fewer bouts of infant fussing and crying at 6 weeks postpartum than mothers in the ETAU group.

Effect: improvement; F (1, 28) = 5.68

Size: F (1, 28) = 5.68
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Mothers who received PREPP reported significantly fewer bouts of infant fussing and crying at 6 weeks postpartum than mothers in the ETAU group.

Effect: improvement; F (1, 28) = 5.68

Size: F (1, 28) = 5.68
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Mothers who received PREPP reported significantly fewer bouts of infant fussing and crying at 6 weeks postpartum than mothers in the ETAU group.

Effect: improvement; F (1, 28) = 5.68

Size: F (1, 28) = 5.68
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Mothers who received PREPP reported significantly fewer bouts of infant fussing and crying at 6 weeks postpartum than mothers in the ETAU group.

Effect: improvement; F (1, 28) = 5.68

Size: F (1, 28) = 5.68
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Mothers who received PREPP reported significantly fewer bouts of infant fussing and crying at 6 weeks postpartum than mothers in the ETAU group.

Effect: improvement; F (1, 28) = 5.68

Size: F (1, 28) = 5.68
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Mothers who received PREPP reported significantly fewer bouts of infant fussing and crying at 6 weeks postpartum than mothers in the ETAU group.

Effect: improvement; F (1, 28) = 5.68

Size: F (1, 28) = 5.68
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Mothers who received PREPP reported significantly fewer bouts of infant fussing and crying at 6 weeks postpartum than mothers in the ETAU group.

Effect: improvement; F (1, 28) = 5.68

Size: F (1, 28) = 5.68
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Mothers who received PREPP reported significantly fewer bouts of infant fussing and crying at 6 weeks postpartum than mothers in the ETAU group.

Effect: improvement; F (1, 28) = 5.68

Size: F (1, 28) = 5.68
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Mothers who received PREPP reported significantly fewer bouts of infant fussing and crying at 6 weeks postpartum than mothers in the ETAU group.

Effect: improvement; F (1, 28) = 5.68

Size: F (1, 28) = 5.68
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Mothers who received PREPP reported significantly fewer bouts of infant fussing and crying at 6 weeks postpartum than mothers in the ETAU group.

Effect: improvement; F (1, 28) = 5.68

Size: F (1, 28) = 5.68
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Mothers who received PREPP reported significantly fewer bouts of infant fussing and crying at 6 weeks postpartum than mothers in the ETAU group.

Effect: improvement; F (1, 28) = 5.68

Size: F (1, 28) = 5.68
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Mothers who received PREPP reported significantly fewer bouts of infant fussing and crying at 6 weeks postpartum than mothers in the ETAU group.

Effect: improvement; F (1, 28) = 5.68

Size: F (1, 28) = 5.68
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Mothers who received PREPP reported significantly fewer bouts of infant fussing and crying at 6 weeks postpartum than mothers in the ETAU group.

Effect: improvement; F (1, 28) = 5.68

Size: F (1, 28) = 5.68
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Mothers who received PREPP reported significantly fewer bouts of infant fussing and crying at 6 weeks postpartum than mothers in the ETAU group.

Effect: improvement; F (1, 28) = 5.68

Size: F (1, 28) = 5.68
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Mothers who received PREPP reported significantly fewer bouts of infant fussing and crying at 6 weeks postpartum than mothers in the ETAU group.

Effect: improvement; F (1, 28) = 5.68

Size: F (1, 28) = 5.68
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Mothers who received PREPP reported significantly fewer bouts of infant fussing and crying at 6 weeks postpartum than mothers in the ETAU group.

Effect: improvement; F (1, 28) = 5.68

Size: F (1, 28) = 5.68
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Mothers who received PREPP reported significantly fewer bouts of infant fussing and crying at 6 weeks postpartum than mothers in the ETAU group.

Effect: improvement; F (1, 28) = 5.68

Size: F (1, 28) = 5.68
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Mothers who received PREPP reported significantly fewer bouts of infant fussing and crying at 6 weeks postpartum than mothers in the ETAU group.

Effect: improvement; F (1, 28) = 5.68

Size: F (1, 28) = 5.68
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Mothers who received PREPP reported significantly fewer bouts of infant fussing and crying at 6 weeks postpartum than mothers in the ETAU group.

Effect: improvement; F (1, 28) = 5.68

Size: F (1, 28) = 5.68
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Mothers who received PREPP reported significantly fewer bouts of infant fussing and crying at 6 weeks postpartum than mothers in the ETAU group.

Effect: improvement; F (1, 28) = 5.68

Size: F (1, 28) = 5.68
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Mothers who received PREPP reported significantly fewer bouts of infant fussing and crying at 6 weeks postpartum than mothers in the ETAU group.

Effect: improvement; F (1, 28) = 5.68

Size: F (1, 28) = 5.68
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Mothers who received PREPP reported significantly fewer bouts of infant fussing and crying at 6 weeks postpartum than mothers in the ETAU group.

Effect: improvement; F (1, 28) = 5.68

Size: F (1, 28) = 5.68
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Mothers who received PREPP reported significantly fewer bouts of infant fussing and crying at 6 weeks postpartum than mothers in the ETAU group.

Effect: improvement; F (1, 28) = 5.68

Size: F (1, 28) = 5.68
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Women who received PREPP decreased significantly in clinician-rated depressive symptoms (HRSD) between pre-randomization and 6 weeks postpartum, while ETAU women showed no significant change.

Effect: improvement; B = −6.54

Size: B = −6.54
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Women who received PREPP decreased significantly in clinician-rated depressive symptoms (HRSD) between pre-randomization and 6 weeks postpartum, while ETAU women showed no significant change.

Effect: improvement; B = −6.54

Size: B = −6.54
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Women who received PREPP decreased significantly in clinician-rated depressive symptoms (HRSD) between pre-randomization and 6 weeks postpartum, while ETAU women showed no significant change.

Effect: improvement; B = −6.54

Size: B = −6.54
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Women who received PREPP decreased significantly in clinician-rated depressive symptoms (HRSD) between pre-randomization and 6 weeks postpartum, while ETAU women showed no significant change.

Effect: improvement; B = −6.54

Size: B = −6.54
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Women who received PREPP decreased significantly in clinician-rated depressive symptoms (HRSD) between pre-randomization and 6 weeks postpartum, while ETAU women showed no significant change.

Effect: improvement; B = −6.54

Size: B = −6.54
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Women who received PREPP decreased significantly in clinician-rated depressive symptoms (HRSD) between pre-randomization and 6 weeks postpartum, while ETAU women showed no significant change.

Effect: improvement; B = −6.54

Size: B = −6.54
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Women who received PREPP decreased significantly in clinician-rated depressive symptoms (HRSD) between pre-randomization and 6 weeks postpartum, while ETAU women showed no significant change.

Effect: improvement; B = −6.54

Size: B = −6.54
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Women who received PREPP decreased significantly in clinician-rated depressive symptoms (HRSD) between pre-randomization and 6 weeks postpartum, while ETAU women showed no significant change.

Effect: improvement; B = −6.54

Size: B = −6.54
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Women who received PREPP decreased significantly in clinician-rated depressive symptoms (HRSD) between pre-randomization and 6 weeks postpartum, while ETAU women showed no significant change.

Effect: improvement; B = −6.54

Size: B = −6.54
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Women who received PREPP decreased significantly in clinician-rated depressive symptoms (HRSD) between pre-randomization and 6 weeks postpartum, while ETAU women showed no significant change.

Effect: improvement; B = −6.54

Size: B = −6.54
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Women who received PREPP decreased significantly in clinician-rated depressive symptoms (HRSD) between pre-randomization and 6 weeks postpartum, while ETAU women showed no significant change.

Effect: improvement; B = −6.54

Size: B = −6.54
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Women who received PREPP decreased significantly in clinician-rated depressive symptoms (HRSD) between pre-randomization and 6 weeks postpartum, while ETAU women showed no significant change.

Effect: improvement; B = −6.54

Size: B = −6.54
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Women who received PREPP decreased significantly in clinician-rated depressive symptoms (HRSD) between pre-randomization and 6 weeks postpartum, while ETAU women showed no significant change.

Effect: improvement; B = −6.54

Size: B = −6.54
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Women who received PREPP decreased significantly in clinician-rated depressive symptoms (HRSD) between pre-randomization and 6 weeks postpartum, while ETAU women showed no significant change.

Effect: improvement; B = −6.54

Size: B = −6.54
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Women who received PREPP decreased significantly in clinician-rated depressive symptoms (HRSD) between pre-randomization and 6 weeks postpartum, while ETAU women showed no significant change.

Effect: improvement; B = −6.54

Size: B = −6.54
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Women who received PREPP decreased significantly in clinician-rated depressive symptoms (HRSD) between pre-randomization and 6 weeks postpartum, while ETAU women showed no significant change.

Effect: improvement; B = −6.54

Size: B = −6.54
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Women who received PREPP decreased significantly in clinician-rated depressive symptoms (HRSD) between pre-randomization and 6 weeks postpartum, while ETAU women showed no significant change.

Effect: improvement; B = −6.54

Size: B = −6.54
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Women who received PREPP decreased significantly in clinician-rated depressive symptoms (HRSD) between pre-randomization and 6 weeks postpartum, while ETAU women showed no significant change.

Effect: improvement; B = −6.54

Size: B = −6.54
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Women who received PREPP decreased significantly in clinician-rated depressive symptoms (HRSD) between pre-randomization and 6 weeks postpartum, while ETAU women showed no significant change.

Effect: improvement; B = −6.54

Size: B = −6.54
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Women who received PREPP decreased significantly in clinician-rated depressive symptoms (HRSD) between pre-randomization and 6 weeks postpartum, while ETAU women showed no significant change.

Effect: improvement; B = −6.54

Size: B = −6.54
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Women who received PREPP decreased significantly in clinician-rated depressive symptoms (HRSD) between pre-randomization and 6 weeks postpartum, while ETAU women showed no significant change.

Effect: improvement; B = −6.54

Size: B = −6.54
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Women who received PREPP decreased significantly in clinician-rated depressive symptoms (HRSD) between pre-randomization and 6 weeks postpartum, while ETAU women showed no significant change.

Effect: improvement; B = −6.54

Size: B = −6.54
PMC4738166
Finding details → · Paper → · Graph →
None
improvement

Women who received PREPP decreased significantly in clinician-rated depressive symptoms (HRSD) between pre-randomization and 6 weeks postpartum, while ETAU women showed no significant change.

Effect: improvement; B = −6.54

Size: B = −6.54
PMC4738166
Finding details → · Paper → · Graph →

Papers (1)